People

Eric Carter

Feldan Therapeutics board member appointed in January2025. Previously chief medical officer and global head of development at Allergan, with more than three decades of clinical and non-clinical pharmaceutical-development experience according to the company. Feldan identifies PhD and MD qualifications.